本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Zenas BioPharma Inc.

31.91
+0.79002.54%
盤前32.490.5800+1.82%07:00 EDT
成交量:63.46萬
成交額:2,003.56萬
市值:20.80億
市盈率:-3.53
高:32.00
開:31.00
低:30.66
收:31.12
52周最高:44.60
52周最低:13.50
股本:6,517.67萬
流通股本:4,502.47萬
量比:1.35
換手率:1.41%
股息:- -
股息率:- -
每股收益(TTM):-9.0522
每股收益(LYR):-8.4448
淨資產收益率:-199.04%
總資產收益率:-34.42%
市淨率:8.42
市盈率(LYR):-3.78

資料載入中...

2026/09/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/09/08

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/09/08

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/13

重要事件披露

Form 8-K - Current report
2026/05/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/13

重要事件披露

Form 8-K - Current report
2026/03/31

重要事件披露

Form 8-K - Current report
2026/03/27

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/03/27

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/03/26

[補充]招股説明書

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/03/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/16

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/16

重要事件披露

Form 8-K - Current report
2026/02/13

重要事件披露

Form 8-K - Current report
2026/01/05

重要事件披露

Form 8-K - Current report
2025/12/19

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/12/16

重要事件披露

Form 8-K - Current report
2025/11/12

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]